Rhythm Biosciences Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
|Primary activities||Research, development and commercialisation of medical diagnostic technology|
|Industry / Sector||Diagnostics & Research / Healthcare|
|Mailing address||Bio21 Institute 30 Flemington Road Parkville VIC 3010 Australia|
|Phone / Fax||61 3 8256 2880 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Rhythm Biosciences paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.RHY dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
RHY's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Oct 2022, following are the company executives and directors listed on Rhythm Biosciences.
|Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD||Exec. Chairman||57||131.25k|
|Mr. Glenn Gilbert||MD, CEO & Director||434.84k|
|Dr. Trevor John Lockett Ph.D.||Technical Director, Chair of the Clinical Advisory Board & Exec. Director||130.01k|
|Ms. Andrea Steele LLB B Com LLM||Gen. Counsel & Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Rhythm Biosciences is and its enterprise value is .
The RHY's stocks Beta value is 3.47 making it 247% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Rhythm Biosciences (RHY)
- Ansell (ANN)
- Cochlear (COH)
- Fisher & Paykel Healthcare Corporation (FPH)
- Estia Health (EHE)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Resmed Inc (RMD)
- Ramsay Health Care (RHC)
- Polynovo (PNV)
- Sonic Healthcare (SHL)
Rhythm Biosciences (ASX:RHY) Frequently Asked Questions
1. What is Rhythm Biosciences's Stock Symbol?
Rhythm Biosciences trades on ASX under the ticker symbol "RHY".
2. What is Rhythm Biosciences's stock price today?
One share of RHY stock can currently be purchased for approximately $1.2.
3. How can I contact Rhythm Biosciences?
Rhythm Biosciences's mailing address is Bio21 Institute 30 Flemington Road Parkville VIC 3010 Australia. The company can be reached via phone at 61 3 8256 2880.
4. What is Rhythm Biosciences's official website?
The official website of Rhythm Biosciences is https://www.rhythmbio.com.
5. Which share registry manages Rhythm Biosciences's stock?
Rhythm Biosciences's stock is managed by LINK MARKET SERVICES LIMITED.